These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27654338)

  • 1. A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid.
    Kaniga K; Cirillo DM; Hoffner S; Ismail NA; Kaur D; Lounis N; Metchock B; Pfyffer GE; Venter A
    J Clin Microbiol; 2016 Dec; 54(12):2963-2968. PubMed ID: 27654338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multilaboratory, Multicountry Study To Determine Bedaquiline MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing.
    Kaniga K; Cirillo DM; Hoffner S; Ismail NA; Kaur D; Lounis N; Metchock B; Pfyffer GE; Venter A
    J Clin Microbiol; 2016 Dec; 54(12):2956-2962. PubMed ID: 27654337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective
    Kaniga K; Hasan R; Jou R; Vasiliauskienė E; Chuchottaworn C; Ismail N; Metchock B; Miliauskas S; Viet Nhung N; Rodrigues C; Shin S; Simsek H; Smithtikarn S; Ngoc ALT; Boonyasopun J; Kazi M; Kim S; Kamolwat P; Musteikiene G; Sacopon CA; Tahseen S; Vasiliauskaitė L; Wu MH; Vally Omar S
    J Clin Microbiol; 2022 Jan; 60(1):e0291920. PubMed ID: 34705538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru.
    Puyén ZM; Santos-Lázaro D; Vigo AN; Coronel J; Alarcón MJ; Cotrina VV; Moore DAJ
    BMC Infect Dis; 2022 Aug; 22(1):705. PubMed ID: 36002805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No in vitro synergistic effect of bedaquiline combined with fluoroquinolones, linezolid, and clofazimine against extensively drug-resistant tuberculosis.
    Pang Y; Jing W; Lu J; Zong Z; Huo F; Dong L; Dai G; Li Y; Huang H; Chu N
    Diagn Microbiol Infect Dis; 2019 Aug; 94(4):361-364. PubMed ID: 30876684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Coban AY; Bilgin K; Uzun M; Durupinar B
    Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates.
    van Ingen J; Simons S; de Zwaan R; van der Laan T; Kamst-van Agterveld M; Boeree MJ; van Soolingen D
    J Clin Microbiol; 2010 Aug; 48(8):2749-53. PubMed ID: 20554815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants.
    Ismail N; Omar SV; Ismail NA; Peters RPH
    J Microbiol Methods; 2018 Oct; 153():1-9. PubMed ID: 30165087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
    Rastogi N; Labrousse V; Goh KS
    Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bedaquiline, Pyrazinamide, Levofloxacin, Linezolid, and Clofazimine Second-line Regimen for Tuberculosis Displays Similar Early Bactericidal Activity as the Standard Rifampin-Based First-line Regimen.
    Zainabadi K; Vilbrun SC; Mathurin LD; Walsh KF; Pape JW; Fitzgerald DW; Lee MH
    J Infect Dis; 2024 Aug; 230(2):e447-e456. PubMed ID: 38060827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
    Cavanaugh JS; Jou R; Wu MH; Dalton T; Kurbatova E; Ershova J; Cegielski JP;
    J Antimicrob Chemother; 2017 Jun; 72(6):1678-1687. PubMed ID: 28333192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates.
    Zhang Z; Li T; Qu G; Pang Y; Zhao Y
    Int J Antimicrob Agents; 2015 Jan; 45(1):71-5. PubMed ID: 25459737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability.
    Gumbo T
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1484-91. PubMed ID: 20086150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo.
    Zhao W; Zheng M; Wang B; Mu X; Li P; Fu L; Liu S; Guo Z
    Int J Infect Dis; 2016 Nov; 52():23-28. PubMed ID: 27613365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of twelve second-line antimicrobial agents against Mycobacterium tuberculosis in Taiwan.
    Lu PL; Peng CF; Hwang JJ; Chen YH
    J Chemother; 2008 Apr; 20(2):202-7. PubMed ID: 18467246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 Decades.
    Forsman LD; Jonsson J; Wagrell C; Werngren J; Mansjö M; Wijkander M; Groenheit R; Hammar U; Giske CG; Schön T; Bruchfeld J
    Clin Infect Dis; 2019 Sep; 69(8):1394-1402. PubMed ID: 30561569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of two methods for the detection of antituberculous drug susceptibility in Mycobacterium tuberculosis complex isolates: sensititre MycoTB MIC plate and the indirect agar proportion methods].
    Varıcı Balcı FK; Çavuşoğlu C
    Mikrobiyol Bul; 2018 Apr; 52(2):123-134. PubMed ID: 29933730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid.
    López-Gavín A; Tudó G; Vergara A; Hurtado JC; Gonzalez-Martín J
    Int J Antimicrob Agents; 2015 Nov; 46(5):582-5. PubMed ID: 26421981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis.
    Schön T; Werngren J; Machado D; Borroni E; Wijkander M; Lina G; Mouton J; Matuschek E; Kahlmeter G; Giske C; Santin M; Cirillo DM; Viveiros M; Cambau E
    Clin Microbiol Infect; 2021 Feb; 27(2):288.e1-288.e4. PubMed ID: 33198949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis].
    Lu Y; Wang B; Zhao WJ; Zheng MQ; Li P; Fu L; Liang BW
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):675-8. PubMed ID: 21092635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.